Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT.
Humans
Graft vs Host Disease
/ immunology
Hematopoietic Stem Cell Transplantation
Leukemia
/ genetics
Minor Histocompatibility Antigens
/ genetics
Transplantation, Homologous
Male
Female
Adolescent
Young Adult
Adult
Middle Aged
HLA Antigens
/ immunology
T-Lymphocytes
/ immunology
Dendritic Cells
/ immunology
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
09 05 2023
09 05 2023
Historique:
accepted:
16
11
2022
received:
01
09
2022
medline:
28
4
2023
pubmed:
9
12
2022
entrez:
8
12
2022
Statut:
ppublish
Résumé
T-cell responses to minor histocompatibility antigens (mHAs) mediate graft-versus-leukemia (GVL) effects and graft-versus-host disease (GVHD) in allogeneic hematopoietic cell transplantation. Therapies that boost T-cell responses improve allogeneic hematopoietic cell transplant (alloHCT) efficacy but are limited by concurrent increases in the incidence and severity of GVHD. mHAs with expression restricted to hematopoietic tissue (GVL mHAs) are attractive targets for driving GVL without causing GVHD. Prior work to identify mHAs has focused on a small set of mHAs or population-level single-nucleotide polymorphism-association studies. We report the discovery of a large set of novel GVL mHAs based on predicted immunogenicity, tissue expression, and degree of sharing among donor-recipient pairs (DRPs) in the DISCOVeRY-BMT data set of 3231 alloHCT DRPs. The total number of predicted mHAs varied by HLA allele, and the total number and number of each class of mHA significantly differed by recipient genomic ancestry group. From the pool of predicted mHAs, we identified the smallest sets of GVL mHAs needed to cover 100% of DRPs with a given HLA allele. We used mass spectrometry to search for high-population frequency mHAs for 3 common HLA alleles. We validated 24 predicted novel GVL mHAs that are found cumulatively within 98.8%, 60.7%, and 78.9% of DRPs within DISCOVeRY-BMT that express HLA-A∗02:01, HLA-B∗35:01, and HLA-C∗07:02, respectively. We confirmed the immunogenicity of an example novel mHA via T-cell coculture with peptide-pulsed dendritic cells. This work demonstrates that the identification of shared mHAs is a feasible and promising technique for expanding mHA-targeting immunotherapeutics.
Identifiants
pubmed: 36477467
pii: 493420
doi: 10.1182/bloodadvances.2022008863
pmc: PMC10182302
doi:
Substances chimiques
Minor Histocompatibility Antigens
0
HLA Antigens
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1635-1649Subventions
Organisme : NCI NIH HHS
ID : F30 CA268748
Pays : United States
Organisme : NHLBI NIH HHS
ID : U24 HL157560
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL128568
Pays : United States
Organisme : NHLBI NIH HHS
ID : OT3 HL147741
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA124766
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL102278
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA247676
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA233032
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA164973
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA188733
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA076518
Pays : United States
Organisme : NHLBI NIH HHS
ID : U24 HL138660
Pays : United States
Informations de copyright
© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Références
Biol Blood Marrow Transplant. 2016 Nov;22(11):2025-2030
pubmed: 27519278
Ann Intern Med. 1994 Apr 15;120(8):646-52
pubmed: 8135448
JAMA Oncol. 2016 Dec 01;2(12):1583-1589
pubmed: 27532508
Front Immunol. 2016 Mar 15;7:100
pubmed: 27014279
Blood. 2001 Oct 15;98(8):2352-7
pubmed: 11588030
Blood. 2007 May 1;109(9):4089-96
pubmed: 17234742
N Engl J Med. 2008 May 1;358(18):1909-18
pubmed: 18450602
Immunol Cell Biol. 2011 Mar;89(3):396-407
pubmed: 21301477
Cancer J. 2004 Jan-Feb;10(1):1-7
pubmed: 15000488
Genome Res. 1999 Aug;9(8):677-9
pubmed: 10447503
Vascul Pharmacol. 2018 Feb;101:38-47
pubmed: 29174013
Genetics. 2007 May;176(1):351-9
pubmed: 17339205
Blood. 2017 Sep 28;130(13):1585-1596
pubmed: 28811306
Front Genet. 2021 Jun 17;12:554948
pubmed: 34220922
Bone Marrow Transplant. 2013 Mar;48(3):346-50
pubmed: 22863723
Lancet. 2009 May 2;373(9674):1550-61
pubmed: 19282026
Blood. 2007 Feb 15;109(4):1355-62
pubmed: 17008540
Clin Cancer Res. 2012 Sep 15;18(18):5099-109
pubmed: 22843789
Biol Blood Marrow Transplant. 2018 Jan;24(1):133-141
pubmed: 28870777
Blood. 2014 Aug 21;124(8):1372-7
pubmed: 24982504
Blood Adv. 2018 Aug 28;2(16):2052-2062
pubmed: 30115642
J Exp Med. 2001 Jan 15;193(2):195-206
pubmed: 11148223
Blood. 2017 Feb 9;129(6):791-798
pubmed: 27872059
Cancers (Basel). 2022 Feb 28;14(5):
pubmed: 35267551
Genome Med. 2015 Nov 20;7:118
pubmed: 26589293
J Exp Med. 2003 Jun 2;197(11):1489-500
pubmed: 12771180
Blood. 2010 May 13;115(19):3869-78
pubmed: 20071660
Front Immunol. 2020 Mar 11;11:381
pubmed: 32218783
N Engl J Med. 2016 Jan 7;374(1):43-53
pubmed: 26735993
Blood. 2000 Sep 15;96(6):2062-8
pubmed: 10979948
J Virol. 2014 Sep;88(18):10613-23
pubmed: 24990997
J Immunol. 2004 Dec 1;173(11):7046-54
pubmed: 15557202
Hum Immunol. 2007 Sep;68(9):779-88
pubmed: 17869653
J Clin Invest. 2005 Dec;115(12):3506-16
pubmed: 16322791
EClinicalMedicine. 2021 Aug 25;40:101093
pubmed: 34746714
Clin Cancer Res. 2016 Aug 15;22(16):4185-96
pubmed: 26964570
Nat Rev Immunol. 2007 May;7(5):340-52
pubmed: 17438575
Blood. 2017 Jan 5;129(1):13-21
pubmed: 27821504
Biol Blood Marrow Transplant. 2017 Nov;23(11):2004-2011
pubmed: 28733264
N Engl J Med. 2012 Oct 18;367(16):1487-96
pubmed: 23075175
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Genome Res. 2011 May;21(5):790-7
pubmed: 21349924
J Immunol. 2017 Nov 1;199(9):3360-3368
pubmed: 28978689
Blood. 2018 May 31;131(22):2490-2499
pubmed: 29610366
Biol Blood Marrow Transplant. 2015 Sep;21(9):1679-1686
pubmed: 26028504
Haematologica. 2012 Aug;97(8):1205-8
pubmed: 22511490
Blood. 2006 May 1;107(9):3779-86
pubmed: 16391015
Bone Marrow Transplant. 2016 Feb;51(2):163-71
pubmed: 26501766
Blood Adv. 2019 Aug 13;3(15):2337-2341
pubmed: 31391166
Front Oncol. 2021 Apr 15;11:666091
pubmed: 33937080
Blood. 1990 Feb 1;75(3):555-62
pubmed: 2297567
Biol Blood Marrow Transplant. 2009 Nov;15(11):1431-8
pubmed: 19822303
Blood. 2007 May 1;109(9):3658-66
pubmed: 17213292
Clin Cancer Res. 2013 Jan 1;19(1):247-57
pubmed: 23147993
Front Genet. 2022 Jun 13;13:901377
pubmed: 35879986